查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1996547

胃食道逆流症治疗设备市场：依产品类型、治疗类型、最终用户和通路划分－2026-2032年全球预测

Gastroesophageal Reflux Disease Devices Market by Product Type, Procedure Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，胃食道逆流症 (GERD) 治疗设备市场价值将达到 11.5 亿美元，到 2026 年将成长至 12.2 亿美元，到 2032 年将达到 20.8 亿美元，复合年增长率为 8.81%。

主要市场统计数据
基准年 2025 11.5亿美元
预计年份：2026年 12.2亿美元
预测年份 2032 20.8亿美元
复合年增长率 (%) 8.81%

全面概述胃食道逆流症 (GERD) 治疗设备的发展趋势以及推动快速创新的临床和商业性因素。

胃食道逆流症 (GERD) 仍然是一种具有重要临床意义的疾病，持续推动内视镜、磁振造影、射频和外科手术等多种治疗方法和医疗设备的创新发展。临床医生和医疗系统日益需要能够减少长期药物依赖、最大限度降低围手术全期风险并实现门诊治疗的干预措施。因此，医疗设备的发展趋势呈现出快速迭代改进、日益关注以患者为中心的治疗结果以及针对门诊治疗优化技术的涌现等特点。

本文详细探讨了正在重塑胃食道逆流症相关医疗设备引入和医疗保健提供者决策的临床、技术和商业性变革。

由于微创平台的治疗方法、磁性括约肌增强技术的成熟以及口腔和内视镜缝合技术的改进，用于治疗胃食道逆流 (GERD) 的器材市场正在经历一场变革。临床医生正在采用兼顾症状控制和解剖结构保护的治疗方法，而器械开发商也在积极响应，推出改进型产品，优先考虑易于实施、可重复性以及减少术中和术后併发症。

对美国在 2025 年实施的累积关税如何重塑供应链、采购方式和医疗设备商业化策略进行策略分析。

2025年生效的美国新关税的累积影响，正在重塑整个胃食道逆流（GERD）治疗设备生态系统的供应链动态、零件采购决策和定价模式。依赖进口零件（例如精密导管、磁性材料和微电子元件）的医疗设备製造商正面临不断上涨的到货成本，这加速了他们对材料清单（BOM）优化和国内及近岸供应商评估的重新审视。因此，采购团队正优先考虑双重采购、长期供应商合约以及增加库存缓衝，以降低成本波动和前置作业时间不确定性。

实用的细分洞察，揭示产品架构、临床环境和通路如何影响竞争定位和采用趋势。

细分市场层面的趋势揭示了产品类型、终端用户和通路之间的显着差异，从而为产品开发重点和商业规划提供了直接的见解。在产品类型细分方面，内视镜缝合器材正在不断发展，竞争性的缝合系统和成熟的平台（如Overstitch）都优先考虑更小的输送尺寸和更高的组织整合一致性。同时，磁性括约肌增强产品也不断演进，从第一代设计发展到专注于可调节性、MRI相容性和简化植入流程的下一代系统。射频消融术器械透过先进的导管系统进行定位，强调病灶控制和能量调节，这与以成本和易用性为主要考虑因素的标准导管系统形成对比。在胃底折迭手术领域，机器人辅助腹腔镜系统凭藉其更佳的操作性和可视性，正与传统腹腔镜系统并驾齐驱，儘管这需要不同的资本投入和培训投入。成熟的系统（如 Esophyx）和新兴的下一代胃底折迭解决方案（代表经口非切口胃底折迭平台）在手术时间、解剖修復耐久性和门诊手术适用性方面展开竞争。

重点区域洞察，阐述美洲、欧洲、中东和非洲以及亚太地区的市场动态如何影响法规、临床实务和供应链策略。

区域趋势对美洲、欧洲、中东、非洲和亚太市场的监管路径、临床部署模式和供应链韧性有显着影响。在美洲，强大的医院网络和不断扩大的门诊手术中心容量为在门诊环境中展现疗效和可靠临床证据的医疗器械提供了支持。同时，在采购週期和与保险公司的谈判中，对整体医疗保健的成本节约效果是关键考虑因素。该地区也是下一代系统早期商业化的中心，临床医生和学术机构检验其临床效用。

重点阐述公司层面的关键洞察，重点介绍平台策略、伙伴关係、临床证据和售后服务如何决定 GERD 设备市场的竞争优势。

胃食道逆流 (GERD) 器材市场的竞争格局受到多种因素的影响，包括成熟的医疗设备公司、高度专业化的新兴企业以及专注于平台扩充性和临床整合的跨产业技术合作伙伴。主要企业正投资于模组化平台策略，以实现功能上的渐进式升级，而无需彻底改造硬件，从而缩短产品迭代周期并减轻监管负担。同时，小规模的创新者正透过解决特定的临床挑战（例如器械小型化、简化部署和改进术后监测）在细分市场站稳脚跟。

为领导者提供有针对性、可操作的建议，以加强供应链、证据生成、培训计划和经营模式，从而加速采用并保护利润率。

产业领导者应优先采取一系列切实可行的行动措施，以克服当前不利因素并抓住新的机会。首先，他们应透过多元化零件采购和考虑将关键子组装流程外包，来降低关税风险并减少前置作业时间波动。在增强价值链韧性的同时，他们还应投资产生符合支付方终点和医院估值框架的临床证据，重点关注耐用性、生活品质 (QOL) 测量和成本抵消分析，以支持在门诊和住院环境中的部署。

高度透明和严谨的调查方法，结合了对临床医生和采购负责人的初步访谈、整合的临床和监管资讯以及供应链映射。

本分析的调查方法结合了结构化的原始研究和严谨的二手研究，并采用迭代检验，以确保其可靠性和可操作性。原始研究包括对临床医生、采购经理、供应链经理和行业高管进行结构化访谈，以了解设备在真实临床环境中的表现、应用障碍和采购偏好。二手研究包括对同行评审的临床文献、监管申报文件、程序规范指南和公开的技术摘要进行系统性回顾，以将设备功能集与临床终点进行映射。

总而言之，整合凸显了协调临床证据、供应链韧性和适应性商业化以主导GERD 设备普及的必要性。

总而言之，胃食道逆流 (GERD)医疗设备市场正处于转折点，其驱动因素包括技术进步、门诊治疗模式的转变以及支付方期望的改变。那些将产品开发与可证实的临床价值相结合、投资于全面的培训和售后服务项目并建立稳健供应链的製造商，将更有利于最大限度地利用向微创、以门诊为中心的治疗路径累积所带来的益处。儘管关税环境和区域监管差异增加了市场的复杂性，但也为企业提供了将生产转移到国内和建立战略伙伴关係关係的奖励，从而能够获得竞争优势。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：胃食道逆流症治疗器材市场：依产品类型划分

  • 内视镜缝合装置
    • 相互竞争的缝合系统
    • 包缝系统
  • 磁性括约肌增强装置
    • 第一代系统
    • 下一代系统
  • 射频消融术装置
    • 先进的导管系统
    • 标准导管系统
  • 外科胃底折迭装置
    • 传统腹腔镜系统
    • 机器人辅助腹腔镜系统
  • 无需口腔切口的胃底折迭装置
    • 脑下垂体系统
    • 新一代胃底折迭手术系统

第九章：胃食道逆流症治疗器材市场－依治疗类型划分

  • 诊断治疗
  • 治疗
    • 内视镜手术
      • 组织增厚
    • 手术治疗
      • 腹腔镜胃底折迭术
      • 电刺激疗法
  • 监测措施
    • 短期住院监测
    • 长期门诊监测

第十章：胃食道逆流症治疗设备市场：依最终用户划分

  • 门诊手术中心
    • 独立设施
    • 医院附设设施
  • 诊所
    • 基层医疗诊所
    • 专科诊所
  • 医院
    • 综合医院
    • 专业医疗中心
      • 胃肠病专科中心
      • 多专科医疗中心

第十一章：胃食道逆流症治疗器材市场：依分销管道划分

  • 直销
  • 线上销售
    • EC平台
    • 製造商门户
  • 第三方经销商
    • 全国销售代理
    • 区域销售代理

第十二章：胃食道逆流症治疗器材市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：胃食道逆流症治疗器材市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：胃食道逆流症治疗器材市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国胃食道逆流症治疗器材市场

第十六章：中国胃食道逆流症治疗器材市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Diversatek Healthcare, Inc.
  • EndoGastric Solutions, Inc.
  • Fujifilm Holdings Corporation
  • GI Dynamics, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Koninklijke Philips NV
  • Laborie Medical Technologies Corp.
  • Mederi Therapeutics, Inc.
  • Medtronic plc
  • Olympus Corporation
  • Pentax Medical
  • Stryker Corporation
  • Torax Medical, Inc.
Product Code: MRR-925E8149CEF2

The Gastroesophageal Reflux Disease Devices Market was valued at USD 1.15 billion in 2025 and is projected to grow to USD 1.22 billion in 2026, with a CAGR of 8.81%, reaching USD 2.08 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.15 billion
Estimated Year [2026] USD 1.22 billion
Forecast Year [2032] USD 2.08 billion
CAGR (%) 8.81%

A comprehensive introduction to the evolving gastroesophageal reflux disease device landscape and the clinical and commercial forces driving rapid innovation

Gastroesophageal reflux disease remains a clinically significant condition that continues to shape procedural innovation and device development across endoscopic, magnetic, radiofrequency, and surgical approaches. Clinicians and health systems are increasingly seeking interventions that reduce long-term medication dependence, minimize perioperative risk, and enable same-day pathways. As a result, the device landscape is characterized by rapid iteration, a heightened focus on patient-centric outcomes, and the emergence of outpatient-optimized technologies.

In parallel, payer scrutiny and hospital procurement cycles are shaping adoption curves, while clinical evidence requirements for safety and durability are becoming more rigorous. Transitioning care away from inpatient admissions toward ambulatory surgical centers and specialized clinics is exerting pressure on device manufacturers to deliver compact, cost-effective, and interoperable systems that integrate with existing operating room technology stacks. Consequently, commercial and clinical leaders must navigate an environment where technological promise must be matched by reproducible clinical performance and viable reimbursement strategies.

An in-depth look at the transformative clinical, technological, and commercial shifts reshaping GERD device adoption and provider decision-making

The landscape for gastroesophageal reflux disease devices is undergoing transformative shifts driven by procedural migration to minimally invasive platforms, the maturation of magnetic sphincter augmentation concepts, and the refinement of transoral and endoscopic suturing techniques. Clinicians are adopting approaches that seek to balance symptom control with anatomical preservation, and device developers are responding with iterations that prioritize ease of deployment, reproducibility, and reduced periprocedural morbidity.

Moreover, surgical fundoplication is evolving through greater use of robotic assistance and enhanced imaging, while radiofrequency ablation systems are differentiating on catheter design and energy delivery precision. These technology advances are occurring alongside broader healthcare system trends such as outpatient care expansion, value-based contracting, and greater emphasis on health economics. Consequently, market participants are compelled to align clinical evidence generation with user training programs and to redesign commercial models to support diverse end users, including freestanding ambulatory centers, hospital-affiliated facilities, and specialty clinics. This period of transformation therefore favors organizations that couple engineering agility with robust clinical validation and adaptive go-to-market strategies.

A strategic analysis of how the cumulative United States tariffs introduced in 2025 are restructuring supply chains, procurement behaviors, and device commercialization strategies

The cumulative effects of new United States tariffs enacted in 2025 are reshaping supply chain strategies, component sourcing decisions, and pricing dynamics across the gastroesophageal reflux disease device ecosystem. Device manufacturers that rely on imported specialty components such as precision catheters, magnetic materials, or microelectronics are experiencing higher landed costs, prompting reassessment of bill-of-materials optimization and accelerated evaluation of domestic or nearshore suppliers. As a result, procurement teams are prioritizing dual-sourcing, longer-term supplier agreements, and increased inventory buffers to mitigate cost volatility and lead-time uncertainty.

In addition, tariff-driven cost pressures are influencing go-to-market choices, with some manufacturers electing to absorb incremental costs to preserve competitive pricing while others are introducing differentiated service bundles to maintain margin. Hospitals and ambulatory surgical centers are responding by intensifying capital allocation reviews and demanding clearer total-cost-of-care narratives from device vendors. The tariff environment is also catalyzing investment in localized assembly and testing capabilities, which reduces exposure to import duties and can shorten regulatory submission timelines for incremental device iterations. Finally, payers and health systems are watching these developments closely, increasingly tying reimbursement conversations to demonstrable value and long-term cost offsets rather than upfront device price alone.

Actionable segmentation insights revealing how product architectures, clinical settings, and distribution pathways influence competitive positioning and adoption dynamics

Segment-level dynamics reveal meaningful differentiation across product types, end users, and distribution avenues that directly inform product development priorities and commercial planning. Within product type segmentation, endoscopic suturing devices are evolving with competitive suturing systems and established Overstitch-like platforms prioritizing smaller-profile delivery and improved tissue apposition consistency, while magnetic sphincter augmentation offerings continue to advance from first generation designs toward next generation systems that focus on adjustability, MRI compatibility, and simplified implantation workflows. Radiofrequency ablation devices are being positioned through advanced catheter systems that emphasize lesion control and energy modulation versus standard catheter systems where cost and ease of use remain dominant considerations. In the surgical fundoplication space, conventional laparoscopic systems are increasingly complemented by robotic assisted laparoscopic systems that offer enhanced dexterity and visualization but require different capital and training commitments. Transoral incisionless fundoplication platforms, represented by entrenched Esophyx-like systems and emergent next generation fundoplication solutions, are competing on procedure time, durability of anatomical repair, and outpatient readiness.

End user segmentation further nuances purchasing behavior and clinical pathways. Ambulatory surgical centers, including both freestanding centers and hospital-affiliated centers, are gravitating toward devices that support short-stay or same-day discharge protocols and that minimize capital footprint. Clinics, whether primary care clinics or specialty clinics, are more selective in device adoption, often focusing on referral networks and diagnostic-to-procedure continuity. Hospitals, including general hospitals and specialty centers, tend to balance surgical volume considerations against training capacity, with gastroenterology specialty centers and multispecialty centers each prioritizing different procedural mixes and post-procedure support models. Distribution channel segmentation highlights that direct sales remain the preferred route for high-touch device adoption, whereas online sales through e-commerce platforms and manufacturer portals are growing for consumables and adjunct tools, and third party distributors, both national and regional, continue to play an essential role in extending reach into varied clinical settings. Collectively, these segmentation insights underscore the need for manufacturers to tailor product feature sets, training programs, and channel strategies to the specific economics and operational constraints of each buyer cohort.

Critical regional insights describing how Americas, Europe Middle East & Africa, and Asia-Pacific market dynamics shape regulatory, clinical, and supply chain strategies

Regional dynamics materially influence regulatory pathways, clinical adoption patterns, and supply chain resilience across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. In the Americas, strong hospital networks and growing ambulatory surgical center capacity favor devices that demonstrate outpatient efficacy and robust clinical evidence, while procurement cycles and payer negotiations place emphasis on demonstrable reductions in total cost of care. This region also serves as a focal point for early commercial launches of next generation systems, where clinician champions and academic centers validate clinical utility.

In Europe Middle East & Africa, regulatory heterogeneity and fragmented reimbursement frameworks mean that market entry strategies must be tailored to country-specific clinical guidelines and procurement practices. Here, value dossiers that address health economic evaluations and real-world evidence can accelerate uptake, particularly in specialty centers that emphasize minimally invasive care. In the Asia-Pacific region, rapid investment in healthcare infrastructure and an expanding base of trained endoscopists and surgeons are driving interest in cost-efficient technologies and scalable training models. Manufacturing and assembly footprints in this region also act as strategic anchors for companies seeking to diversify supply chains and reduce exposure to import tariffs, while local clinical studies and partnerships with regional opinion leaders can meaningfully influence adoption.

Key company-level insights highlighting how platform strategies, partnerships, clinical evidence, and aftermarket services determine competitive advantage in the GERD devices market

Competitive dynamics in the gastroesophageal reflux disease device arena are influenced by a mix of established medical device organizations, specialized emerging firms, and cross-sector technology partners focused on platform scalability and clinical integration. Leading players are investing in modular platform strategies that enable incremental feature upgrades without wholesale reinvention of hardware, thereby shortening product iteration cycles while managing regulatory burden. Concurrently, smaller innovators are carving niche positions by solving specific clinical pain points such as device profile reduction, simplified deployment, or improved post-procedure monitoring.

Strategic partnerships and selective acquisitions are common as companies seek to combine clinical credibility with commercialization scale, and aftermarket services-such as procedural training, proctoring, and disposable consumable programs-are increasingly important revenue and retention levers. Intellectual property portfolios and the depth of clinical evidence are crucial differentiators that influence hospital formulary decisions and payer discussions. Finally, companies that integrate digital health capabilities, patient-reported outcome tracking, and remote follow-up tools are more likely to secure long-term contracts with health systems seeking comprehensive care pathways rather than standalone devices.

Targeted and practical recommendations for leaders to fortify supply chains, evidence generation, training programs, and commercial models to accelerate adoption and protect margin

Industry leaders should prioritize a set of practical, execution-focused actions to navigate current headwinds and capture emerging opportunities. First, diversify component sourcing and consider nearshoring critical subassembly processes to mitigate tariff exposure and reduce lead-time variability. Parallel to supply chain resilience, invest in clinical evidence generation that aligns with payer endpoints and hospital value frameworks, focusing on durability, quality-of-life measures, and cost-offset analyses that support adoption across ambulatory and hospital settings.

Second, design training and proctoring programs that lower the procedural learning curve and enable rapid scale within ambulatory surgical centers and specialty clinics, thereby expanding addressable use cases. Third, adopt flexible commercial models that combine direct sales for high-touch conversions with expanded e-commerce and distributor partnerships for consumables and adjuncts, while negotiating bundled pricing or subscription approaches that align incentives with long-term outcomes. Fourth, accelerate development of next generation device features such as MRI-safe materials, adjustable magnetic constructs, and advanced catheter control to differentiate product roadmaps. Fifth, engage proactively with regulators and payers to streamline coverage pathways and to influence clinical guideline inclusion. Finally, implement scenario planning for tariff shifts and reimbursement changes to ensure pricing agility and to preserve investments in R&D and clinician engagement.

A transparent and rigorous research methodology combining primary clinician and procurement interviews with secondary clinical and regulatory synthesis and supply chain mapping

The research methodology underpinning this analysis combines structured primary inquiry with rigorous secondary synthesis and iterative validation to ensure credibility and actionable relevance. Primary research involved structured interviews with clinicians, procurement leaders, supply chain managers, and industry executives to capture real-world device performance, adoption barriers, and procurement preferences. Secondary research included systematic review of peer-reviewed clinical literature, regulatory filings, procedure coding guidelines, and publicly available technology briefs to map device feature sets and clinical endpoints.

Data triangulation was applied by cross-referencing interview insights with regulatory documentation and manufacturer technical specifications. Supply chain mapping leveraged trade flows, component sourcing patterns, and manufacturing footprint analyses to interpret tariff impacts and logistical constraints. Quality control measures included peer review by clinical experts and methodologists, reconciliation of divergent viewpoints, and transparent documentation of assumptions. Limitations are acknowledged where regional data gaps exist or where long-term durability evidence is still maturing, and the report recommends periodic updates as additional real-world evidence and regulatory decisions become available.

Concluding synthesis emphasizing the imperative to align clinical evidence, supply chain resilience, and adaptive commercialization to lead in GERD device adoption

In summary, the gastroesophageal reflux disease device market is at an inflection point driven by technological refinement, procedural migration to ambulatory settings, and evolving payer expectations. Manufacturers that align product development with demonstrable clinical value, invest in robust training and aftercare programs, and build resilient supply chains will be best positioned to capitalize on the shift toward minimally invasive and outpatient-centric care pathways. The cumulative tariff environment and regional regulatory heterogeneity add complexity, but they also create incentives for onshoring and strategic partnerships that can yield competitive advantage.

Ultimately, success will hinge on the ability to translate clinical promise into reproducible outcomes, to present clear value propositions to payers and providers, and to execute adaptable commercial models that reflect the operational realities of ambulatory surgical centers, clinics, and hospitals. Stakeholders who combine clinical rigor, supply chain foresight, and customer-centric commercialization will lead the next wave of adoption and shape long-term standards of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroesophageal Reflux Disease Devices Market, by Product Type

  • 8.1. Endoscopic Suturing Devices
    • 8.1.1. Competitor Suturing Systems
    • 8.1.2. Overstitch Systems
  • 8.2. Magnetic Sphincter Augmentation Devices
    • 8.2.1. First Generation Systems
    • 8.2.2. Next Generation Systems
  • 8.3. Radiofrequency Ablation Devices
    • 8.3.1. Advanced Catheter Systems
    • 8.3.2. Standard Catheter Systems
  • 8.4. Surgical Fundoplication Devices
    • 8.4.1. Conventional Laparoscopic Systems
    • 8.4.2. Robotic Assisted Laparoscopic Systems
  • 8.5. Transoral Incisionless Fundoplication Devices
    • 8.5.1. Esophyx Systems
    • 8.5.2. Next Generation Fundoplication Systems

9. Gastroesophageal Reflux Disease Devices Market, by Procedure Type

  • 9.1. Diagnostic Procedures
  • 9.2. Therapeutic Procedures
    • 9.2.1. Endoscopic Procedures
      • 9.2.1.1. Tissue Bulking Procedures
    • 9.2.2. Surgical Procedures
      • 9.2.2.1. Laparoscopic Fundoplication Procedures
      • 9.2.2.2. Electrical Stimulation Procedures
  • 9.3. Monitoring Procedures
    • 9.3.1. Short-Term In-Hospital Monitoring
    • 9.3.2. Long-Term Ambulatory Monitoring

10. Gastroesophageal Reflux Disease Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Freestanding Centers
    • 10.1.2. Hospital Affiliated Centers
  • 10.2. Clinics
    • 10.2.1. Primary Care Clinics
    • 10.2.2. Specialty Clinics
  • 10.3. Hospitals
    • 10.3.1. General Hospitals
    • 10.3.2. Specialty Centers
      • 10.3.2.1. Gastroenterology Specialty Centers
      • 10.3.2.2. Multispecialty Centers

11. Gastroesophageal Reflux Disease Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Sales
    • 11.2.1. E Commerce Platforms
    • 11.2.2. Manufacturer Portals
  • 11.3. Third Party Distributors
    • 11.3.1. National Distributors
    • 11.3.2. Regional Distributors

12. Gastroesophageal Reflux Disease Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastroesophageal Reflux Disease Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastroesophageal Reflux Disease Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Gastroesophageal Reflux Disease Devices Market

16. China Gastroesophageal Reflux Disease Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Becton, Dickinson and Company
  • 17.7. Boston Scientific Corporation
  • 17.8. Cook Medical LLC
  • 17.9. Diversatek Healthcare, Inc.
  • 17.10. EndoGastric Solutions, Inc.
  • 17.11. Fujifilm Holdings Corporation
  • 17.12. GI Dynamics, Inc.
  • 17.13. Intuitive Surgical, Inc.
  • 17.14. Johnson & Johnson
  • 17.15. KARL STORZ SE & Co. KG
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Laborie Medical Technologies Corp.
  • 17.18. Mederi Therapeutics, Inc.
  • 17.19. Medtronic plc
  • 17.20. Olympus Corporation
  • 17.21. Pentax Medical
  • 17.22. Stryker Corporation
  • 17.23. Torax Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TISSUE BULKING PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TISSUE BULKING PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TISSUE BULKING PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LAPAROSCOPIC FUNDOPLICATION PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LAPAROSCOPIC FUNDOPLICATION PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LAPAROSCOPIC FUNDOPLICATION PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SHORT-TERM IN-HOSPITAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SHORT-TERM IN-HOSPITAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SHORT-TERM IN-HOSPITAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LONG-TERM AMBULATORY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LONG-TERM AMBULATORY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LONG-TERM AMBULATORY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET S